Compare TeraWulf Inc (WULF) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TeraWulf Inc vs 22nd Century Group Inc — how do they compare? TeraWulf Inc trades at $20.04 (market cap $9.35B), while 22nd Century Group Inc trades at $4.48 (market cap $1.49M). The key difference: TeraWulf Inc is far larger — about 6275.2× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| WULF | XXII | |
|---|---|---|
Market Cap | $9.35B | $1.49M |
Sector | Technology | Technology |
52-Week High | $28.98 | $1.07K |
52-Week Low | $4.76 | $3.90 |
Enterprise Value | $12.03B | -$6.74M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TeraWulf (WULF) trades at $18.86, up 3.85% today, amid volatile AI infrastructure sector movements. The stock shows bearish technical signals with negative earnings trends, having missed Q1-Q3 2025-2026 EPS estimates. Fundamentally, the company reported a net loss of $661.42M on $168.46M revenue in 2025, though it secured a significant 20-year, $19B deal with Anthropic for AI data center capacity.
Despite unanimous analyst buy ratings and a $37.22 consensus price target suggesting 97% upside, WULF faces execution risks from high cash burn and negative margins. The Anthropic partnership offers long-term revenue potential but requires substantial capital investment amid competitive and regulatory pressures in the AI infrastructure space.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
